Hyaluronidase Effect on Infusion Set Life

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Hyaluronidase

150 units/ml - subjects injected 1 milliliter (ml) into the catheter hub prior to connecting the insulin infusion set on Day 1 and 3 of infusion set wear.

OTHER

Control

No hyaluronidase administered into insulin infusion set.

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

Stanford University

OTHER

NCT02199028 - Hyaluronidase Effect on Infusion Set Life | Biotech Hunter | Biotech Hunter